Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes
Clinical trial NCT03655535 · COMPLETED
Trial details
- NCT number
- NCT03655535
- Sponsor
- Boston Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2019-08-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.